Immunological aspects of corneal graft rejection and own experience in immunosuppressive therapy in high risk patients;Immunologiczne aspekty choroby przeszczepu oraz doświadczenia własne ze stosowania terapii immunosupresyjnej u pacjentów wysokiego ryzyka

Klinika Oczna

Volumn 106, Issue 3 SUPPL., 2004, Pages 485-488

  Kamińska, Anna ^a   Szaflik, Jerzy ^a   Minkiewicz Timler, Grazyna ^a   Sybilska, Małgorzata ^a   Pawluczyk Dyjecińska, Martyna ^a   Smolarek, Monika ^a  

^a NONE

Author keywords

Graft rejection; High risk corneal grafting; Immune privilege; Immunosuppressive therapy

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CORNEA TRANSPLANTATION; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOLOGY; INCIDENCE; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; VISUAL ACUITY;

ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; CHILD; CORNEAL TRANSPLANTATION; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; VISUAL ACUITY;

EID: 15744390765     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bilingham R. E., Boswell T.: Studies on the problem of corneal homografts. Proc. R. Soc. Lond. B., 1953, 141, 293-406.
2. The Collaborative Corneal Transplantation Studies Research Group. The Collaborative Corneal Transplantation Studies (CCTS): Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch. Ophthalmol., 1992, 110, 1392-403.
3. Hill J. C.: Immunosuppression in corneal transplantation. Eye, 1995, 9, 247-253.
4. Hill J. C.: Systemic cyclosporine in high-risk keratoplasty: short versus long term therapy. Ophthalmology, 1994, 101, 128-133.
5. Niederkorn J. Y.: Immune privilege and immune regulation in the eye. Adv. Immunol., 1990, 48, 191-226.
6. Price F. W., Whitson W. E., Collins K. S., Marks R. G.: Five-year corneal raft survival. A large, single-center patient cohort. Arch. Ophthalmol., 1993, 111, 799-805.
7. Rumelt S., Bersudsky V., Blum-Hareuvani T., Rehany U.: Systemic cyclosporin A in high failure risk, repeated corneal transplantation. Br. J. Ophthalmol., 2002, 86, 988-992.
8. Streilein J. W.: New thoughts on the immunology of corneal transplantation. Eye, 2003, 17, 943-948.
9. Streilein J. W., Yamada J., Dana M. R., Ksander B. R.: Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transplant. Proc., 1999, 31, 1472.
10. Sundmacher R., Reinhard T., Heering P.: Six years experience with systemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients. Ger. J. Ophtalmol., 1992, 1, 432-436.
11. Williams K. A., Coster D. J.: Penetrating corneal transplantation in the inbred rat: a new model. Invest. Ophthalmol. Vis. Sci., 1985, 26, 23-30.
12. Williams K. A., Erickson S., Coster D. J.: Topical steroid, cyclosporin A, and the outcome of rat corneal allografts. Br. J. Ophthalmol., 1987, 71, 239-242.